BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26450380)

  • 1. Measurement of Antibody-Mediated Reduction of Plasmodium yoelii Liver Burden by Bioluminescent Imaging.
    Sack BK; Miller JL; Vaughan AM; Kappe SH
    Methods Mol Biol; 2015; 1325():69-80. PubMed ID: 26450380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for in vivo assessment of humoral protection against malaria sporozoite challenge by passive transfer of monoclonal antibodies and immune serum.
    Sack BK; Miller JL; Vaughan AM; Douglass A; Kaushansky A; Mikolajczak S; Coppi A; Gonzalez-Aseguinolaza G; Tsuji M; Zavala F; Sinnis P; Kappe SH
    Infect Immun; 2014 Feb; 82(2):808-17. PubMed ID: 24478094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Parasite Liver-Stage Burden in Human-Liver Chimeric Mice.
    Foquet L; Meuleman P; Hermsen CC; Sauerwein R; Leroux-Roels G
    Methods Mol Biol; 2015; 1325():59-68. PubMed ID: 26450379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative bioluminescent imaging of pre-erythrocytic malaria parasite infection using luciferase-expressing Plasmodium yoelii.
    Miller JL; Murray S; Vaughan AM; Harupa A; Sack B; Baldwin M; Crispe IN; Kappe SH
    PLoS One; 2013; 8(4):e60820. PubMed ID: 23593316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.
    Putrianti ED; Silvie O; Kordes M; Borrmann S; Matuschewski K
    J Infect Dis; 2009 Mar; 199(6):899-903. PubMed ID: 19434915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.
    Sack BK; Keitany GJ; Vaughan AM; Miller JL; Wang R; Kappe SH
    PLoS Pathog; 2015 May; 11(5):e1004855. PubMed ID: 25974076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice.
    Vaughan AM; Sack BK; Dankwa D; Minkah N; Nguyen T; Cardamone H; Kappe SHI
    Infect Immun; 2018 May; 86(5):. PubMed ID: 29440367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy.
    Witney AA; Doolan DL; Anthony RM; Weiss WR; Hoffman SL; Carucci DJ
    Mol Biochem Parasitol; 2001 Dec; 118(2):233-45. PubMed ID: 11738713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily Plasmodium yoelii infective mosquito bites do not generate protection or suppress previous immunity against the liver stage.
    Pollock T; Leitao R; Galan-Rodriguez C; Wong KA; Rodriguez A
    Malar J; 2011 Apr; 10():97. PubMed ID: 21501513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
    Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
    Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage.
    Rénia L; Rodrigues MM; Nussenzweig V
    Immunology; 1994 May; 82(1):164-8. PubMed ID: 7913914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Plasmodium berghei and Plasmodium yoelii Liver-Stage Parasite Burden by Quantitative Real-Time PCR.
    Pichugin A; Krzych U
    Methods Mol Biol; 2015; 1325():81-9. PubMed ID: 26450381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
    Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
    Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
    Leite JA; Bargieri DY; Carvalho BO; Albrecht L; Lopes SC; Kayano AC; Farias AS; Chia WN; Claser C; Malleret B; Russell B; Castiñeiras C; Santos LM; Brocchi M; Wunderlich G; Soares IS; Rodrigues MM; Rénia L; Costa FT
    Infect Immun; 2015 Oct; 83(10):3781-92. PubMed ID: 26169268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    Speake C; Pichugin A; Sahu T; Malkov V; Morrison R; Pei Y; Juompan L; Milman N; Zarling S; Anderson C; Wong-Madden S; Wendler J; Ishizuka A; MacMillen ZW; Garcia V; Kappe SH; Krzych U; Duffy PE
    PLoS One; 2016; 11(7):e0159449. PubMed ID: 27434123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
    Ophorst OJ; Radosević K; Havenga MJ; Pau MG; Holterman L; Berkhout B; Goudsmit J; Tsuji M
    Infect Immun; 2006 Jan; 74(1):313-20. PubMed ID: 16368986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.